Skills Group for Youth at Clinical High-Risk for Psychosis
Testing the Feasibility of a Skills Group for Adolescents and Young Adults at Clinical High-risk for Psychosis
2 other identifiers
interventional
30
1 country
1
Brief Summary
This study is intended to test the feasibility of an integrated cognitive behavioral therapy (CBT) and dialectical behavioral therapy (DBT) skills group for adolescents and young adults at clinical high-risk (CHR) for psychosis. The current study applies a skills group drawing from evidence-based practices (e.g., cognitive behavioral therapy (CBT), dialectical behavioral therapy (DBT)) to those at CHR for psychosis. Up to 30 CHR individuals (starting with a minimum of 3 participants, N accounts for attrition as well), aged 13-18, already receiving clinical services within the HOPE team at University of Pittsburgh will be offered a weekly skills group. Data collected on feasibility and outcome measures will occur pre (within 1 month) -post (up to 4-5 months) and half-way (up to 2-3 months) through the intervention. Taken together, the aim of the proposed intervention is to provide novel insights regarding the utility of a newly developed intervention that integrates both CBT and DBT skills for those at CHR for psychosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 26, 2022
CompletedFirst Submitted
Initial submission to the registry
May 15, 2022
CompletedFirst Posted
Study publicly available on registry
May 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
February 10, 2026
February 1, 2026
4.7 years
May 15, 2022
February 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Attrition
Feasibility measure; this will be assessed by recording the number of individuals that discontinued group participation.
Up to 5 months
Attendance
Feasibility measure; daily attendance will be recorded.
Up to 5 months
Modified Quick Lecomte and Leclerc Scale
Feasibility measure; this modified measure is a a 15-item feasibility measure that assesses feelings about the relevance and importance of group, alliance with the therapists, the group cohesion, appreciation of the group therapy, optimism for the future (five items), feelings about self and others (two items), current mood/anxiety (seven items), distressing thoughts (one item), and feelings about meeting goals (one item). The measure collects data on a 3-point likert scale (0-2), with higher score indicating more group satisfaction/improvement. A mean total score will be collected for each dimension and can range from 0-2. An improvement score taking the proportion of better than usual compared to worse than usual can be calculated for each month of therapy as well.
Up to 5 months
Participation Scale
Feasibility measure; this is a 9-item checklist assessing the participation and behavior of each group member, with each item rated on a 0 (absence of behavior) to 4 (strong presence of behavior) scale. A total score is computed for each person (range 0-36 scale), as well as an average for all group members, with higher scores indicating more group engagement and prosocial behaviors.
Up to 5 months
Change from baseline in the participant group survey at up to 3 months
Feasibility measure; this includes 3 questions about the goals for group and asks general questions about how different areas of the individual's life is going (e.g., feeling present, coping with stress, feeling towards self, 10 questions ranging from 0-40) - individuals are to answer on a 0 (much worse) to 4 (greatly improved) scale with higher scores signaling more improvement. Furthermore, this questionnaire also includes questions about the quality of the group from the participants perspective which will provide qualitative data.
Baseline vs. up to 3 months
Change from up to 3 months in the participant group survey at up to 5 months
Feasibility measure; this includes 3 questions about the goals for group and asks general questions about how different areas of the individual's life is going (e.g., feeling present, coping with stress, feeling towards self, 10 questions ranging from 0-40) - individuals are to answer on a 0 (much worse) to 4 (greatly improved) scale with higher scores signaling more improvement. Furthermore, this questionnaire also includes questions about the quality of the group from the participants perspective which will provide qualitative data.
Up to 3 months vs up to 5 months
Change from baseline in the participant group survey at up to 5 months
Feasibility measure; this includes 3 questions about the goals for group and asks general questions about how different areas of the individual's life is going (e.g., feeling present, coping with stress, feeling towards self, 10 questions ranging from 0-40) - individuals are to answer on a 0 (much worse) to 4 (greatly improved) scale with higher scores signaling more improvement. Furthermore, this questionnaire also includes questions about the quality of the group from the participants perspective which will provide qualitative data.
Baseline vs. up to 5 months
Change from baseline in Satisfaction with Therapy and Therapist Scale at up to 3 months
A satisfaction 13-item scale that asks the individual to indicate their level of satisfaction of the therapy and therapists in the group treatment. Scores fall on a 1 (strong disagree) to 5 (strongly agree) scale with higher numbers indicating higher satisfaction. Scores range from 12-60. There is an additional item that falls on a 1-5 scale that asks about how the tre (atment helped with the specific problem that led to therapy, with higher scores indicating that therapy made things worse (range is 1-5).
Baseline vs. up to 3 months
Change from 3 months in Satisfaction with Therapy and Therapist Scale at up to 5 months
A satisfaction 13-item scale that asks the individual to indicate their level of satisfaction of the therapy and therapists in the group treatment. Scores fall on a 1 (strong disagree) to 5 (strongly agree) scale with higher numbers indicating higher satisfaction. Scores range from 12-60. There is an additional item that falls on a 1-5 scale that asks about how the tre (atment helped with the specific problem that led to therapy, with higher scores indicating that therapy made things worse (range is 1-5).
Up to 3 months vs. up to 5 months.
Fidelity scores
Fidelity scores developed specifically for this group asking questions about the structure of the group meant to be filled out by co-leaders (e.g., was there a mindfulness practice in the session?). Each item can have a Yes or No response. More Yes responses indicate more fidelity. There are a total of 9 items.
Up to 5 months
Secondary Outcomes (43)
Change from baseline in Lehman Quality of Life Functional Assessment at up to 3 months.
Baseline vs. up to 3 months
Change from up to 3 months in Lehman Quality of Life Functional Assessment at up to 5 months.
Up to 3 months vs. up to 5 months
Change from baseline in Lehman Quality of Life Functional Assessment at up to 5 months.
Baseline vs. up to 5 months
Change from baseline in Perceived Stress Scale at up to 3 months
Baseline to up to 3 months
Change from up to 3 months in Perceived Stress Scale at up to 5 months.
Up to 3 months vs. up to 5 months
- +38 more secondary outcomes
Study Arms (1)
Skills Group
EXPERIMENTALThere will be one condition which is the group and participants will complete feasibility and outcome measures at baseline, at midpoint, and at the end of the group.
Interventions
Adolescents and young adults with a CHR syndrome ages 13-18 will complete feasibility and outcome measures while participating in a weekly skills group for 6 months.
Eligibility Criteria
You may qualify if:
- years of age
- Meet criteria for clinical high-risk syndrome (i.e., at clinical high risk for developing a psychotic disorder). CHR status is determined based off of scoring a 3 (moderate) - 5 (severe) on the Structured Interview for Psychosis-Risk Syndromes and/or having a first degree relative with psychotic disorder and/or the individual meets criteria for schizotypal personality disorder. Additionally individuals with a brief intermittent psychotic symptoms can be included as well (e.g., frankly psychotic symptoms that are very brief)
- Individuals must be enrolled in the HOPE team at the University of Pittsburgh since this group is embedded within that service
You may not qualify if:
- Group member meeting criteria for a current/past psychotic disorder
- Must be the parent, legal guardian of a 13-18 year-old
- For parents of CHR adolescents, their adolescent must meet criteria for a psychosis-risk syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bellefield Towers
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (32)
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
PMID: 6668417BACKGROUNDBeck AT, Baruch E, Balter JM, Steer RA, Warman DM. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr Res. 2004 Jun 1;68(2-3):319-29. doi: 10.1016/S0920-9964(03)00189-0.
PMID: 15099613BACKGROUNDCane, D.B. Olinger, L.J,. Gotlib, I.H., Kuiper, N.A. (1986) Factor structure of the Dysfunctional Attitude Scale in a student population. J Clin Psychol. 42, 307 - 309 .
BACKGROUNDBenedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998). The Hopkins verbal learning test-revised: Normative data and analysis of interform and test-retest reliability. Clinical Neuropsychologist, 12, 43-55.
BACKGROUNDKeefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004 Jun 1;68(2-3):283-97. doi: 10.1016/j.schres.2003.09.011.
PMID: 15099610BACKGROUNDGreco LA, Lambert W, Baer RA. Psychological inflexibility in childhood and adolescence: development and evaluation of the Avoidance and Fusion Questionnaire for Youth. Psychol Assess. 2008 Jun;20(2):93-102. doi: 10.1037/1040-3590.20.2.93.
PMID: 18557686BACKGROUNDCornblatt BA, Auther AM, Niendam T, Smith CW, Zinberg J, Bearden CE, Cannon TD. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull. 2007 May;33(3):688-702. doi: 10.1093/schbul/sbm029. Epub 2007 Apr 17.
PMID: 17440198BACKGROUNDLee, R. M., & Robbins, S. B. (1995). Measuring belongingness: The Social Connectedness and the Social Assurance Scales. Journal of Counseling Psychology, 42, 232-241.
BACKGROUNDMiller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, Hoffman R, Davidson L. Symptom assessment in schizophrenic prodromal states. Psychiatr Q. 1999 Winter;70(4):273-87. doi: 10.1023/a:1022034115078.
PMID: 10587984BACKGROUNDLoewy RL, Pearson R, Vinogradov S, Bearden CE, Cannon TD. Psychosis risk screening with the Prodromal Questionnaire--brief version (PQ-B). Schizophr Res. 2011 Jun;129(1):42-6. doi: 10.1016/j.schres.2011.03.029. Epub 2011 Apr 20.
PMID: 21511440BACKGROUNDMcGlashan, T. H., Walsh, B. C., Woods, S. W., Addington, J., Cadenhead, K., Cannon, T., & Walker, E. (2001). Structured interview for psychosis-risk syndromes. New Haven, CT: Yale School of Medicine.
BACKGROUNDPelletier-Baldelli A, Strauss GP, Visser KH, Mittal VA. Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS). Schizophr Res. 2017 Nov;189:43-49. doi: 10.1016/j.schres.2017.01.055. Epub 2017 Feb 8.
PMID: 28189529BACKGROUNDBECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004. No abstract available.
PMID: 13688369BACKGROUNDBeck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.
PMID: 3204199BACKGROUNDKenardy JA, Spence SH, Macleod AC. Screening for posttraumatic stress disorder in children after accidental injury. Pediatrics. 2006 Sep;118(3):1002-9. doi: 10.1542/peds.2006-0406.
PMID: 16950991BACKGROUNDBernstein, D., & Fink, L. (1998). Childhood Trauma Questionnaire: A retrospective self-report. San Antonio, TX: The Psychological Corporation.
BACKGROUNDLynch, T. R. (2018b). Radically Open Dialectical Behavior Therapy: Theory and practice for treating disorders of overcontrol. Reno, NV: Context Press, an imprint of New Harbinger Publications, Inc.
BACKGROUNDGreco LA, Baer RA, Smith GT. Assessing mindfulness in children and adolescents: development and validation of the Child and Adolescent Mindfulness Measure (CAMM). Psychol Assess. 2011 Sep;23(3):606-14. doi: 10.1037/a0022819.
PMID: 21480722BACKGROUNDGross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers Soc Psychol. 2003 Aug;85(2):348-62. doi: 10.1037/0022-3514.85.2.348.
PMID: 12916575BACKGROUNDLecomte, T., Leclerc, C. & Wykes, T. 2003. Quick LL. Group CBT for Psychosis: A Guidebook for Clinicians.
BACKGROUNDFusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rossler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkotter J, McGuire P, Yung A. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013 Jan;70(1):107-20. doi: 10.1001/jamapsychiatry.2013.269.
PMID: 23165428BACKGROUNDLynch TR, Hempel RJ, Dunkley C. Radically Open-Dialectical Behavior Therapy for Disorders of Over-Control: Signaling Matters. Am J Psychother. 2015;69(2):141-62. doi: 10.1176/appi.psychotherapy.2015.69.2.141.
PMID: 26160620BACKGROUNDMcCauley E, Berk MS, Asarnow JR, Adrian M, Cohen J, Korslund K, Avina C, Hughes J, Harned M, Gallop R, Linehan MM. Efficacy of Dialectical Behavior Therapy for Adolescents at High Risk for Suicide: A Randomized Clinical Trial. JAMA Psychiatry. 2018 Aug 1;75(8):777-785. doi: 10.1001/jamapsychiatry.2018.1109.
PMID: 29926087BACKGROUNDLinehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A, Neacsiu AD, McDavid J, Comtois KA, Murray-Gregory AM. Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry. 2015 May;72(5):475-82. doi: 10.1001/jamapsychiatry.2014.3039.
PMID: 25806661BACKGROUNDStrauss GP, Pelletier-Baldelli A, Visser KF, Walker EF, Mittal VA. A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis. Schizophr Res. 2020 Aug;222:104-112. doi: 10.1016/j.schres.2020.04.019. Epub 2020 Jun 7.
PMID: 32522469BACKGROUNDLenz, A.S., James, P., Stewart, C. et al. A Preliminary Validation of the Youth Over- and Under-Control (YOU-C) Screening Measure with a Community Sample. Int J Adv Counselling 43, 489-503 (2021). https://doi.org/10.1007/s10447-021-09439-9
BACKGROUNDLehman, A., Kernan, E., & Postrado, L.Toolkit Evaluating Quality of Life for Persons with Severe Mental Illness. https://www.hsri.org/publication/toolkit_evaluating_quality_of_life_for_persons_with_severe_mental_illn
BACKGROUNDLehman, A.F. (1988). A quality of life interview for the chronically mentally ill. Evaluation and Program Planning, 11, 51-62.
BACKGROUNDOei, Tian Po & Green, Angela. (2008). The Satisfaction With Therapy and Therapist Scale-Revised (STTS-R) for Group Psychotherapy: Psychometric Properties and Confirmatory Factor Analysis. Professional Psychology Research and Practice. 39. 10.1037/0735-7028.39.4.435.
BACKGROUNDRitsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: psychometric properties of a new measure. Psychiatry Res. 2003 Nov 1;121(1):31-49. doi: 10.1016/j.psychres.2003.08.008.
PMID: 14572622BACKGROUNDWoods SW, Lympus C, McGlashan TH, Walsh BC, Cannon TD. The Mini-SIPS: development of a brief clinical structured interview guide to diagnosing DSM-5 Attenuated Psychosis Syndrome and training outcomes. BMC Psychiatry. 2022 Dec 13;22(1):784. doi: 10.1186/s12888-022-04406-z.
PMID: 36514073BACKGROUNDGupta T, Antezana L, Porter C, Mayanil T, Bylsma LM, Maslar M, Horton LE. Skills program for awareness, connectedness, and empowerment: A conceptual framework of a skills group for individuals with a psychosis-risk syndrome. Front Psychiatry. 2023 Mar 2;14:1083368. doi: 10.3389/fpsyt.2023.1083368. eCollection 2023.
PMID: 37025348DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Leslie Horton, PhD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- There is one condition so masking is not relevant
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 15, 2022
First Posted
May 31, 2022
Study Start
April 26, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
February 10, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Starting 6 months after publication
- Access Criteria
- Data sharing will be occur when specific requests to analyze data are made by investigators in the field and in line with grant funder data sharing policies
All IPD underlying publication will be shared including data dictionaries after publication and in line with the grantee policies regarding data sharing. Data will be de-identified before sharing.